Salomon & Ludwin’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
Other funds holding DGX
Salomon & Ludwin's DGX Position: Q3 2026 in Review
Salomon & Ludwin held its Quest Diagnostics (DGX) position steady in Q3 2026 at 703 shares worth $164K. The position accounts for 0.01% of the portfolio, ranked #189.
Salomon & Ludwin first reported a position in DGX in Q3 2023 and has held it in 13 quarters since. 1,137 funds tracked by Wall St. Rank hold DGX as of Q3 2026.
- Salomon & Ludwin held 703 shares of Quest Diagnostics worth $164K as of Q3 2026.
- Salomon & Ludwin left its Quest Diagnostics share count unchanged in Q3 2026.
- Quest Diagnostics made up 0.01% of Salomon & Ludwin's portfolio in Q3 2026, its #189 holding.
- Salomon & Ludwin first reported a position in Quest Diagnostics in Q3 2023 and has held it in 13 quarters since.
- 1,137 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2026.
Based on Salomon & Ludwin's 13F filing for Q3 2026, filed 29 Oct 2026.